Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALIROCUMAB for Ill-defined disorder: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 8 adverse event reports in the FDA FAERS database where ALIROCUMAB was used for Ill-defined disorder.

Most Reported Side Effects for ALIROCUMAB

Side Effect Reports % Deaths Hosp.
Myalgia 1,571 6.9% 1 79
Product dose omission 1,354 5.9% 1 63
Injection site pain 1,220 5.3% 4 34
Muscle spasms 1,113 4.9% 2 35
Arthralgia 993 4.3% 3 50
Fatigue 922 4.0% 6 69
Pain 892 3.9% 2 76
Pain in extremity 888 3.9% 1 58
Product dose omission issue 864 3.8% 0 30
Injection site bruising 821 3.6% 2 26
Device issue 785 3.4% 0 23
Influenza like illness 778 3.4% 0 23
Diarrhoea 738 3.2% 1 82
Headache 718 3.1% 1 61
Injection site erythema 679 3.0% 0 25

Other Indications for ALIROCUMAB

Hypercholesterolaemia (4,924) Hyperlipidaemia (3,317) Blood cholesterol increased (2,246) Type iia hyperlipidaemia (1,913) Product used for unknown indication (1,704) Blood cholesterol (1,299) Type v hyperlipidaemia (902) Arteriosclerosis (417) Blood cholesterol abnormal (345) Low density lipoprotein increased (326)

Other Drugs Used for Ill-defined disorder

IBUPROFEN (707) ATORVASTATIN (570) DAPAGLIFLOZIN (556) SERTRALINE (437) AMLODIPINE (415) ROSUVASTATIN (361) OMEPRAZOLE (272) DOXYCYCLINE (254) PREGABALIN (248) LANSOPRAZOLE (227)

Related Pages

ALIROCUMAB Full Profile All Ill-defined disorder Drugs ALIROCUMAB Demographics ALIROCUMAB Timeline